Electrical Safety and EMC Testing Under the IEC 60601 Series

1. Key takeaways

Active medical devices must submit test evidence for electrical safety — typically under the IEC 60601-1 series, including the applicable collateral standards and particular standards — and for electromagnetic compatibility (EMC), typically under IEC 60601-1-2. Products containing wireless functionality must additionally assess wireless coexistence; and at the same time, electronic products that emit radiation must also meet the radiation control requirements of FD&C Act Subchapter C. A powered device therefore typically sits at the intersection of several evidence streams at once, and the submission is only complete when each stream has been identified and closed. Because the streams run on different timetables — standards testing, wireless assessment, and the radiation report — the practical work is first to map them and then to sequence them so that none is discovered late.

• Electrical safety evidence is built on the applicable set of IEC 60601-1 series standards — basic, collateral, and particular — not on the basic standard alone.
• EMC evidence covers both emissions and immunity under IEC 60601-1-2.
• Wireless coexistence is an additional assessment item for products with Wi-Fi, Bluetooth, or cellular functions.
• Radiation-emitting electronic products follow a separate legal track under FD&C Act Subchapter C, including product reports and an accession number needed at customs.

2. Legal basis

The instruments listed below, as cited in the source material, cover the recognized standards for safety and EMC, the statutory radiation control track, and the submission procedure.

3. Expert insights

Insight one: IEC 60601-1 is a series, not a single standard.

Beyond the basic safety standard IEC 60601-1, there are collateral standards covering topics such as alarms, the home environment, and EMC — and particular standards addressed to specific device types. When selecting standards, the applicable particular standard number must be determined according to the product type; carrying out only the basic standard is usually insufficient. A test program scoped to the basic standard alone leaves the device-type-specific risks unexamined, and the gap is visible to any reviewer familiar with the product category. Identifying the particular standard early also shapes the test laboratory selection, since not every laboratory holds the accreditation for every particular standard.

Insight two: the EMC assessment covers two directions — emissions and immunity.

IEC 60601-1-2 examines both the electromagnetic disturbances the equipment emits toward its environment and the equipment’s ability to withstand the external electromagnetic environment. Test evidence must be provided for both directions, and the laboratory report must show them separately. The two directions fail differently — emissions problems surface as interference with other equipment, immunity problems as malfunction of the device itself — and neither set of results can stand in for the other in the dossier. A report that presents only one direction is incomplete on its face, and completing it later reopens scheduling at the laboratory that no project plan enjoys.

Insight three: wireless coexistence is an additional assessment item for products with wireless functionality.

According to the relevant FDA guidance, products containing wireless communication functions — Wi-Fi, Bluetooth, cellular — must assess their ability to coexist wirelessly in the electromagnetic environment of intended use. This part belongs to advisory guidance content, but in practice it has already become a routine requirement. Devices that share spectrum with everyday consumer traffic are expected to show that their performance holds up in that traffic, and the assessment is planned as part of the test program rather than appended after the fact. Coexistence failures found late tend to force design changes, whereas found early they only force a schedule.

Insight four: radiation-emitting electronic products travel on a separate legal track.

FD&C Act Subchapter C, the radiation control provisions for electronic products, requires conformance with performance standards, labeling, and the submission of radiation safety product reports. Once a product report is received by FDA, it receives an accession number, and that number must be provided at the time of import declaration. The track is separate from device review, but it converges at the border: an import that cannot present its accession number encounters difficulties that no clean 510(k) record can cure. Planning the report submission alongside the device submission keeps the two tracks on one timeline.

4. Practical recommendations

• Determine the full set of applicable IEC 60601 series standards for the product type — basic, collateral, and particular — and record it as a list.
• Scope the EMC testing to cover both emissions and immunity.
• For products with wireless functionality, add the wireless coexistence assessment.
• Where the product is a radiation-emitting electronic product, submit the radiation safety product report early and obtain the accession number.
• Verify each standard version against the FDA-recognized consensus standards database.
• Sequence the electrical safety, EMC, wireless coexistence, and radiation report workstreams on one master timeline for the project.

5. Verification checklist

• □ The list of applicable IEC 60601 series standards has been drawn up (basic plus collateral plus particular)
• □ The electrical safety test report is complete
• □ EMC testing has covered both the emissions and the immunity directions
• □ The wireless coexistence assessment has been completed for products with wireless functionality
• □ Where the product is a radiation-emitting electronic product, the radiation safety product report has been submitted and the accession number obtained
• □ The standard versions have been verified against the FDA-recognized consensus standards database

Regulatory information verified as of October 28, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, US Agent and local testing support for the United States market. Our team manages FDA establishment registration and listing, 510(k)/De Novo/PMA submissions, and supports post-market reporting obligations. Business enquiries: info@grzanglobal.com